Viewing Study NCT00004058


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT00004058
Status: TERMINATED
Last Update Posted: 2010-01-26
First Post: 1999-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Sponsor: University of Medicine and Dentistry of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Diseases View
None Precancerous/Nonmalignant Condition View
Keywords:

Keywords

Keyword Brief Keyword Text View
None monoclonal gammopathy of undetermined significance View
None recurrent adult Hodgkin lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None isolated plasmacytoma of bone View
None extramedullary plasmacytoma View
None refractory multiple myeloma View
None Waldenstrom macroglobulinemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None polycythemia vera View
None chronic idiopathic myelofibrosis View
None essential thrombocythemia View
None refractory hairy cell leukemia View
None refractory anemia View
None refractory anemia with ringed sideroblasts View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None chronic myelomonocytic leukemia View
None T-cell large granular lymphocyte leukemia View
None acute undifferentiated leukemia View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None secondary acute myeloid leukemia View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None primary central nervous system lymphoma View
None prolymphocytic leukemia View
None primary systemic amyloidosis View
None recurrent mantle cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None anaplastic large cell lymphoma View
None refractory cytopenia with multilineage dysplasia View
None recurrent mycosis fungoides/Sezary syndrome View
None chronic eosinophilic leukemia View
None chronic neutrophilic leukemia View
None atypical chronic myeloid leukemia View
None myelodysplastic/myeloproliferative disease, unclassifiable View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View